International Journal of Critical Illness and Injury Science

REVIEW ARTICLE
Year
: 2013  |  Volume : 3  |  Issue : 2  |  Page : 143--151

Prophylaxis and treatment of venous thromboembolism in the critically ill


Sarah M Adriance, Claire V Murphy 
 Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus OH, USA

Correspondence Address:
Sarah M Adriance
Department of Pharmacy, The Ohio State University Wexner Medical Center, 410 W. 10th Ave, 368 Doan Hall, Columbus, OH
USA

Venous thromboembolism (VTE) is a frequent complication in critically ill patients and is associated with increased rates of morbidity and mortality. The use of thromboprophylaxis to reduce the risk of VTE in this patient population is the standard of care. This review will summarize the recommendations set forth in consensus guidelines for the prevention and treatment of VTE across subgroups within the critically ill patient population. In addition, the drug properties of the recommended pharmacologic agents for thromboprophylaxis will be highlighted including their pharmacokinetics, dosing and complications. The critical care practitioner may also encounter novel oral anticoagulants with increasing frequency. These agents will be briefly reviewed in terms of their approved and investigational indications and the clinical concerns related to their use will also be discussed.


How to cite this article:
Adriance SM, Murphy CV. Prophylaxis and treatment of venous thromboembolism in the critically ill.Int J Crit Illn Inj Sci 2013;3:143-151


How to cite this URL:
Adriance SM, Murphy CV. Prophylaxis and treatment of venous thromboembolism in the critically ill. Int J Crit Illn Inj Sci [serial online] 2013 [cited 2019 Dec 8 ];3:143-151
Available from: http://www.ijciis.org/article.asp?issn=2229-5151;year=2013;volume=3;issue=2;spage=143;epage=151;aulast=Adriance;type=0